Shae Paschal, DPM
Foot & Ankle Surgery · Arlington, TXNPI 1942431341
Payments from drug & device makers
Across 58 payments — averaging $34.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$487
- Bone Support Inc.$292
- Smith+Nephew$207
- Melinta Therapeutics, LLC$137
- Integra Lifesciences Corporation$120
- Fusion Orthopedics USA, LLC$109
- plus $672 from 16 others
What the payments were for
- Travel & lodging$40%
- Food & beverage$2,020100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 14 | $487 |
| Bone Support Inc. | 2 | $292 |
| Smith+Nephew | 11 | $207 |
| Melinta Therapeutics, LLC | 3 | $137 |
| Integra Lifesciences Corporation | 1 | $120 |
| Fusion Orthopedics USA, LLC | 1 | $109 |
| Abbott | 1 | $107 |
| Sandoz | 4 | $85 |
| Misonix Inc | 1 | $67 |
| Zyla Life Sciences, Inc. | 3 | $50 |
| Osteomed LLC | 1 | $48 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $46 |
| Averitas Pharma Inc. | 1 | $45 |
| Nevro Corp. | 1 | $38 |
| Amgen | 2 | $37 |
| Bioventus LLC | 1 | $28 |
| Reprise Biomedical, Inc. | 1 | $28 |
| Tactile Systems Technology Inc | 2 | $25 |
| Merck | 2 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Polynovo North America LLC | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$359
- CERAMENTBONE VOID FILLER$292
- CERAMENT G$292
- INFINITY ADAPTIS$139
- INTEGRA DERMAL REGENERATION TEMPLATE$120
- PRIMATRIX$120
- Santyl$112
- REGRANEX$112
- Oasis$112
- Supera peripheral stent system$107
- Baxdela$103
How this compares
$2,024 in reported general payments places this provider in the 30th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 50 | $2,063 |
| Doxycycline Monohydrate | 32 | $563 |
| Ketoconazole | 30 | $555 |
| Clindamycin Hcl | 73 | $462 |
| Gabapentin | 17 | $333 |
| Methylprednisolone | 21 | $153 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $147 |
| Cephalexin | 23 | $103 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Arlington
- Donald StewartArlington$61K
- Richard PollakSan Antonio$6.1M
- Joseph CaporussoMcAllen$6M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Chad HowzeSan Antonio$2.4M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$972K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.